论文信息 - Two cases of acute myelogenous leukemia with high terminal deoxynucleotidyl transferase activity responding to vincristine-prednisolone treatment with complete remission.

Two cases of acute myelogenous leukemia with high terminal deoxynucleotidyl transferase activity responding to vincristine-prednisolone treatment with complete remission.

Increased TdT activity was demonstrated in 2 cases of AML. One of them had Ph1 positive chromosome due to a standard translocation of t(9:22). Treatment with cytosine arabinoside, daunorubicin, 6-mercaptopurine and prednisolone was ineffective or only partially effective. Switching to the vincristine and prednisolone therapy resulted in a complete remission in both cases.

[1] A. Sandberg,et al. Chromosomes and causation of human cancer and leukemia. XXXII. Unusual features of Ph1‐positive acute myeloblastic leukemia (AML), including a review of the literature , 1979, Cancer.

[2] D. Baltimore,et al. Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia: a co-operative study. , 1978, The New England journal of medicine.

[3] M. Oshimura,et al. Chromosomes and causation of human cancer and leukemia. XXV. Significance of the Ph1 (including unusual translocations) in various acute leukemias , 1977, Cancer.

[4] A. Sandberg. The chromosomes and causation of human cancer and leukemia. , 1966, Cancer research.

[5] F. Takaku,et al. Terminal deoxynucleotidyl transferase activity and B cell markers in chronic myelogenous leukemia blast crisis. , 1979, Acta Haematologica.